Home RxNorm 2709231 influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2709231
RxNorm name influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension
Display name influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension
Full name influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension
Term type SY
Status DailyMed mapping
Updated 2026-06-04 23:39:00 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103914 Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent Influenza Virus Vaccine 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 5fe0ce14-bc11-4b43-b002-7efdca0d3003 influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable Suspension [SCD] · influenza virus vaccine 2025 (trivalent - Croatia/Victoria/Michigan) Injectable Suspension [SY] 3 12 These highlights do not include all the information needed to use Fluzone® safely and effectively. See full prescribing information for Fluzone. Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2025–2026 Formula Initial U.S. Approval: 1980 20260325